17-50354465-G-GC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_022167.4(XYLT2):c.692dupC(p.Val232fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,028 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000082 ( 0 hom. )
Consequence
XYLT2
NM_022167.4 frameshift
NM_022167.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.682
Genes affected
XYLT2 (HGNC:15517): (xylosyltransferase 2) The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-50354465-G-GC is Pathogenic according to our data. Variant chr17-50354465-G-GC is described in ClinVar as [Pathogenic]. Clinvar id is 207977.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XYLT2 | NM_022167.4 | c.692dupC | p.Val232fs | frameshift_variant | 3/11 | ENST00000017003.7 | NP_071450.2 | |
XYLT2 | XM_005257572.5 | c.596dupC | p.Val200fs | frameshift_variant | 3/11 | XP_005257629.1 | ||
XYLT2 | XM_047436522.1 | c.101dupC | p.Val35fs | frameshift_variant | 3/11 | XP_047292478.1 | ||
XYLT2 | NR_110010.2 | n.707dupC | non_coding_transcript_exon_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XYLT2 | ENST00000017003.7 | c.692dupC | p.Val232fs | frameshift_variant | 3/11 | 1 | NM_022167.4 | ENSP00000017003.2 | ||
XYLT2 | ENST00000376550.7 | n.692dupC | non_coding_transcript_exon_variant | 3/10 | 1 | ENSP00000365733.3 | ||||
XYLT2 | ENST00000507602.5 | c.692dupC | p.Val232fs | frameshift_variant | 3/10 | 2 | ENSP00000426501.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1459862Hom.: 0 Cov.: 33 AF XY: 0.00000826 AC XY: 6AN XY: 726264
GnomAD4 exome
AF:
AC:
12
AN:
1459862
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
726264
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74328
GnomAD4 genome
AF:
AC:
2
AN:
152166
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2017 | - - |
Spondylo-ocular syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 04, 2015 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 10, 2023 | This sequence change creates a premature translational stop signal (p.Val232Glyfs*54) in the XYLT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XYLT2 are known to be pathogenic (PMID: 26027496, 26987875). This variant is present in population databases (rs759761618, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with spondyloocular syndrome (PMID: 26027496). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 207977). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at